(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.64% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.83%.
Mckesson's revenue in 2025 is $387,094,000,000.On average, 20 Wall Street analysts forecast MCK's revenue for 2026 to be $50,905,470,392,750, with the lowest MCK revenue forecast at $48,930,150,286,150, and the highest MCK revenue forecast at $53,434,359,024,600. On average, 18 Wall Street analysts forecast MCK's revenue for 2027 to be $55,147,520,926,600, with the lowest MCK revenue forecast at $51,674,912,128,850, and the highest MCK revenue forecast at $58,739,483,294,900.
In 2028, MCK is forecast to generate $59,639,880,706,650 in revenue, with the lowest revenue forecast at $54,722,809,823,950 and the highest revenue forecast at $64,908,347,261,900.